Novartis AG (NVS)

86.99
2.50 2.79
NYSE : Health Technology
Prev Close 89.49
Open 87.65
Day Low/High 86.90 / 87.84
52 Wk Low/High 74.97 / 96.31
Volume 2.52M
Avg Volume 1.86M
Exchange NYSE
Shares Outstanding 2.55B
Market Cap 224.37B
EPS 5.50
P/E Ratio 16.66
Div & Yield 1.84 (2.07%)
European Stocks Slip as Attention Turns to Central Bank Meetings

European Stocks Slip as Attention Turns to Central Bank Meetings

Europe's major markets move lower Tuesday as investors warily turn their attention to the pending Federal Reserve and the Bank of Japan meetings.

Oct. 27 Premarket Briefing: 10 Things You Should Know

Oct. 27 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are trading lower Tuesday ahead of the start of a two-day meeting of the Federal Reserve and earnings from Apple.

3 Drugs Stocks Dragging The Industry Down

3 Drugs Stocks Dragging The Industry Down

TheStreet highlights 3 stocks pushing the drugs industry lower today.

Northwest Bio Bothers British Bestie for Bounteous Bucks

Northwest Bio Bothers British Bestie for Bounteous Bucks

British investor Woodford appears to be the only institutional investor supporting Northwest Bio and its claims of "encouraging interim clinical data" from its DCVax-L and DCVax-Direct cancer immunotherapy clinical programs.

3 Stocks Dragging In The Health Care Sector

3 Stocks Dragging In The Health Care Sector

TheStreet highlights 3 stocks pushing the health care sector lower today.

Eli Lilly Shares Are Stuck in the Doghouse

Eli Lilly Shares Are Stuck in the Doghouse

Shares of Eli Lilly trade at a premium to the pharmaceutical group but the pipeline carries significant risks going forward.

Biogen's MS Drug Trials Beat Competitors’ Results

We believe the biotech's multiple sclerosis treatment, MT-1303, could boost its market-leading position.

3 Drugs Stocks Moving The Industry Upward

3 Drugs Stocks Moving The Industry Upward

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Bristol, Exelixis Drugs Demonstrate Treatment Benefit in Kidney Cancer

Bristol, Exelixis Drugs Demonstrate Treatment Benefit in Kidney Cancer

Bristol's Opdivo is likely to be used ahead of Exelixis' Cometriq to treat advanced kidney cancer patients, doctor says.

3 Drugs Stocks Pushing Industry Growth

3 Drugs Stocks Pushing Industry Growth

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Novartis (NVS): Today's Pre-Market Leader Stock

Novartis (NVS): Today's Pre-Market Leader Stock

Trade-Ideas LLC identified Novartis (NVS) as a pre-market leader candidate

Eli Lilly Diabetes Drug Data Seen As 'Nothing Short Of Extraordinary'

Eli Lilly Diabetes Drug Data Seen As 'Nothing Short Of Extraordinary'

Shares of Eli Lilly rallied yesterday after the company reported data from a study of its type 2 diabetes drug...

Biotech Stock Mailbag: Bristol, Exelixis, Lion Bio, GW Pharma

Biotech Stock Mailbag: Bristol, Exelixis, Lion Bio, GW Pharma

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Global Stocks Fall After the Federal Reserve Keeps Rates at Record Low

And four other things you need to know now.

ZS Pharma Buyout Price Seen As Nearing $100 Per Share

ZS Pharma Buyout Price Seen As Nearing $100 Per Share

The shares of ZS Pharma are rising after the company and Actelion confirmed last night that they had held preliminary talks about a possible strategic transaction.

Drugs Stocks On The Rise With Help From 3 Stocks

Drugs Stocks On The Rise With Help From 3 Stocks

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Biogen Takes on Celgene With New Autoimmune License Deal

Biogen Takes on Celgene With New Autoimmune License Deal

Biogen stepped into the oral S1P modulator race Wednesday with the acquisition of a license to develop a mid-stage compound from Japan's Mitsubishi Tanabe Pharma.

Sept. 2 Premarket Briefing: 10 Things You Should Know

Sept. 2 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are pointing to a rebound for Wall Street on Wednesday after the Dow and S&P 500 posted their third-biggest daily declines of the year on Tuesday.

Put Impax, Akorn and Sagent on Your Watch List of Generics Targets

Put Impax, Akorn and Sagent on Your Watch List of Generics Targets

If companies such as Teva and Perrigo continue to seek growth through acquisitions, they may gobble up Impax Laboratories, Akorn Pharmaceuticals or Sagent Pharmaceuticals.

Trade-Ideas: Novartis (NVS) Is Today's Pre-Market Mover With Heavy Volume Stock

Trade-Ideas: Novartis (NVS) Is Today's Pre-Market Mover With Heavy Volume Stock

Trade-Ideas LLC identified Novartis (NVS) as a pre-market mover with heavy volume candidate

How Google Wants to Help Change Diabetes Forever

How Google Wants to Help Change Diabetes Forever

Google Life Sciences and DexCom are joining forces to change the way the country's 29 million diabetics measure blood sugar, hoping to eliminate the finger prick forever.

August 21 Premarket Briefing: 10 Things You Should Know

August 21 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are trading lower Friday after an ugly day in the market Thursday. Oil prices declined, Asian stocks dropped sharply and European stocks fell too.

European Stocks Fall Further as Volatility Outweighs Strong Economic Data

European Stocks Fall Further as Volatility Outweighs Strong Economic Data

European markets fell on Friday, following another selloff in Asia, as investors remained largely unmoved by relatively upbeat data on the eurozone manufacturing and services sectors.

When Eyeing Small Biotechs, Partnerships Are Huge

When Eyeing Small Biotechs, Partnerships Are Huge

Key collaboration deals with deeper-pocketed concerns can improve the odds of investment success.

4 Pharmaceutical Stocks to Buy in Wake of Shire-Baxalta Bid

4 Pharmaceutical Stocks to Buy in Wake of Shire-Baxalta Bid

With Shire offering to acquire Baxalta for more than $30 billion, we decided to check TheStreet Quant Ratings for stocks in the pharmaceuticals subsector that would be good investments.

Novartis (NVS) Moving On Heavy Volume In The Pre-Market Hours

Novartis (NVS) Moving On Heavy Volume In The Pre-Market Hours

Trade-Ideas LLC identified Novartis (NVS) as a pre-market mover with heavy volume candidate

Quant Picks: 4 Pharmaceutical Companies to Add to Your Porfolio

Quant Picks: 4 Pharmaceutical Companies to Add to Your Porfolio

Here are some of the best pharmaceuticals our algorithm says you should consider looking at.

3 Stocks Driving The Drugs Industry Higher

3 Stocks Driving The Drugs Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Is the U.S. Bull Market Starting to Lose Its Luster?

Is the U.S. Bull Market Starting to Lose Its Luster?

CNBC’s ‘Fast Money’ traders take a closer look at U.S. stocks, as the selloff in China weighs on the market.

3 High-Dividend Pharmaceutical Stocks to Buy

3 High-Dividend Pharmaceutical Stocks to Buy

With Eli Lilly & Co. experimenting with a new drug for Alzheimer's disease, we decided to check Quant Ratings for pharmaceutical stocks to buy.

TheStreet Quant Rating: A- (Buy)